title: Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.
abstract: Although cytomegalovirus (CMV) expresses proteins that interfere with antigen presentation by class I major histocompatibility complex (MHC) molecules, CD8+ cytotoxic T cells (CTLs) are indispensable for controlling infection and maintaining latency. Here, a cytokine flow cytometry assay that employs fibroblasts infected with a mutant strain of CMV (RV798), which is deleted of the 4 viral genes that are responsible for interfering with class I MHC presentation, was used to examine the frequency and specificity of the CD8+ CTLs to CMV in immunocompetent CMV-seropositive individuals. A large fraction of the CD8+ CTL response was found to be specific for viral antigens expressed during the immediate early and early phases of virus replication and presented by fibroblasts infected with RV798 but not wild-type CMV. These results demonstrate that the inhibition of class I antigen presentation observed in CMV-infected cells in vitro is not sufficient to prevent the induction of a broad repertoire of CD8+ CTLs after natural infection in vivo. Thus, reconstitution of T-cell immunity in immunodeficient patients by cell therapy or by vaccination may need to target multiple viral antigens to completely restore immunologic control of CMV.
authors.affiliation: Fred Hutchinson Cancer Research Center, D3-100, 1100 Fairview Ave N, Seattle, WA 98109, USA. tmanley@fhcrc.org
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Manley
authors.forename: Lisa
authors.initials: L
authors.lastname: Luy
authors.forename: Thomas
authors.initials: T
authors.lastname: Jones
authors.forename: Michael
authors.initials: M
authors.lastname: Boeckh
authors.forename: Helen
authors.initials: H
authors.lastname: Mutimer
authors.forename: Stanley R
authors.initials: SR
authors.lastname: Riddell
mesh_terms: D017951:Antigen Presentation; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D003586:Cytomegalovirus Infections / Q000276:immunology*; D005347:Fibroblasts / Q000821:virology; D005434:Flow Cytometry; D017781:Genes, Immediate-Early; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D009154:Mutation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014764:Viral Proteins / Q000276:immunology* / Q000502:physiology
chemical_list: D000956:Antigens, Viral; D015395:Histocompatibility Antigens Class I; D014764:Viral Proteins